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Viral infection is an inherently stressful event. Virus replication taxes cellular biosynthetic machinery and produces
ligands that activate antiviral responses which impair normal cell function. These virus-induced stressors alter
cell function, in part by activating a family of four kinases that phosphorylate the translation initiation factor
eIF2α, leading to a dramatic reduction in protein synthesis. While eIF2α kinase activation typically inhibits virus
replication, human cytomegalovirus (HCMV) efficiently replicates in the presence of persistent cell stress. Here we
review the ways in which HCMV infection induces cellular stress responses and the mechanisms HCMV uses to
evade and manipulate these responses to its own ends.
Human cytomegalovirus
Human cytomegalovirus (HCMV) is a large (>230 kB) dsDNA virus of the betaherpesvirus family, encoding over
200 open reading frames [1]. HCMV has a long replication cycle that is characterized by extensive manipulation of
host signaling processes. Infection activates multiple cell stress response pathways, including the antiviral interferon
pathway and the unfolded protein response [2], which if left unchecked, would inhibit HCMV replication. However,
HCMV heavily regulates each of these stress response pathways, constraining aspects that limit virus replication
while activating others that benefit the virus [3]. Induction of stress response pathways often activates at least one
of four kinases that phosphorylate and inactivate a critical translation factor, the eIF2 complex. Here, we review
how HCMV regulates the activity of eIF2α kinases to enhance virus replication and discuss remaining questions
regarding the control of cellular stress responses by HCMV.
eIF2α kinases & mRNA translation
eIF2α kinases play a critical role in matching the cell’s protein synthesis capacity to the cellular environment. A
variety of stressors activate eIF2α kinases (described below), resulting in phosphorylation of their substrate, the
eIF2α subunit of the eIF2 translation initiation factor complex. The eIF2 complex plays a critical role in translation
initiation as part of the ternary complex, which consists of eIF2, GTP and a charged methionyl tRNA. The ternary
complex binds the 40S ribosomal subunit to form the 43S preinitiation complex, which is then recruited to the
5′ end of an mRNA by the eIF4F cap-binding complex. Together these factors constitute the 48S complex, which
scans the 5′ untranslated region (5′UTR) of the mRNA until recognizing a translation start site. Upon start site
recognition, the GTP in the ternary complex is hydrolyzed and eIF2-GDP is released into the cytosol. The eIF2B
subunit of eIF2 then exchanges GDP for GTP, allowing recharged eIF2 to participate in a subsequent round of
initiation. Phosphorylation of eIF2α by an eIF2α kinase greatly increases its affinity for eIF2B, preventing GTP
exchange. As eIF2α is present in significant excess to eIF2B, even small increases in eIF2α phosphorylation rapidly
deplete the pool of active eIF2 available for ternary complex formation. Thus, eIF2α kinase activation leads to
a significant inhibition of translation initiation and overall levels of protein synthesis. The mechanisms used by
HCMV to prevent eIF2α phosphorylation during infection, despite significant cellular stress, are discussed below.
Human cytomegalovirus & eIF2α kinases
Throughout infection, HCMV generates cellular stresses that are potent activators of eIF2α kinases. However, very
little eIF2α phosphorylation is observed in infected cells and only during the late stage of the virus lytic cycle [4],
suggesting that HCMV actively prevents eIF2α kinase activation. The mechanism(s) used by HCMV to inhibit or
counteract activation of two eIF2α kinases, protein kinase R (PKR) and PKR-like endoplasmic reticulum kinase
(PERK), is well described [4–9]. The potential role of the other eIF2α kinases, HRI and GCN2, during HCMV
infection is less clear, however they could play beneficial or inhibitory roles in virus replication.
Protein kinase R
Perhaps the best characterized eIF2α kinase during HCMV infection is PKR, a critical component of the cell
intrinsic antiviral response [10]. PKR is activated upon binding to dsRNAs produced during viral infection. Binding
to dsRNA induces PKR homodimerization and subsequent activating autophosphorylation. Activated PKR then
binds and phosphorylates eIF2α, leading to a significant decrease in the translation of both cellular and viral
mRNAs and thus, decreased virus replication.
Almost all known viruses express factors that inhibit PKR activation or limit eIF2α phosphorylation in infected
cells. Some viruses produce RNAs that bind PKR and prevent its activation, such as the adenovirus VAI RNA [11]
and Epstein-Barr virus (EBV) EBER RNAs [12]. Other viruses encode proteins that inhibit PKR activation and
eIF2α phosphorylation. The herpes simplex virus 1 (HSV-1) US11 protein prevents PKR activation [13,14], while
the HSV-1 ICP 34.5 protein recruits the host protein phosphatase 1 (PP1) to de-phosphorylate eIF2α in order to
maintain sufficient levels of active ternary complex [15]. Thus, inhibition of PKR activation is a conserved strategy
used by many viruses to ensure efficient replication.
dsRNA ligands for PKR accumulate during HCMV replication [14], likely due to transcription from overlapping
regions of both strands of the viral genome. HCMV encodes two PKR antagonists, pTRS1 and pIRS1, that limit
PKR activation through two distinct mechanisms. Both pTRS1 and pIRS1 contain a noncanonical RNA binding
domain that binds dsRNA [5], although with relatively low affinity compared with PKR. However, the combined
levels of pTRS1 and pIRS1 exceed that of PKR in HCMV infected cells, possibly allowing the two proteins to
compete with PKR for dsRNA ligand binding [5]. In addition, both proteins directly bind PKR, independent of
an RNA intermediate [7–8,16]. The ability of pTRS1 to bind PKR is necessary for inhibition of PKR activation
during HCMV infection, in the absence of pIRS1. In transfected cells, pTRS1 binds the PKR eIF2α contact site
and inhibits PKR kinase activity [7]. Thus, HCMV encodes two viral proteins, pTRS1 and pIRS1, that together
prevent PKR activation to ensure the continued synthesis of viral proteins.
Protein kinase R-like endoplasmic reticulum kinase
High levels of protein synthesis, as occurs during the late phase of HCMV infection, can overwhelm the folding
capacity of the endoplasmic reticulum (ER). The presence of unfolded proteins in the ER initiates a coordinated
cellular response, called the unfolded protein response (UPR). The UPR is activated when unfolded proteins
accumulate in the ER, competing the ER chaperone BiP away from its normal binding partners, the ER sensors
ATF6, IRE-1 and PERK [17]. Loss of BiP binding, activates each sensor and initiates a series of events designed
to re-establish cellular homeostasis. UPR activation triggers cleavage of the membrane bound ATF6 precursor
protein releasing the mature ATF6 transcription factor to induce the expression of ER chaperones, including BiP
itself [18]. The UPR also stimulates the IRE-1 protein, leading to activation of the Xbp-1 transcription factor, which
drives expression of protein degradation factors such as EDEM. HCMV manipulates these arms of the UPR to its
advantage [2,3]. For example, HCMV induces the expression of ATF6 dependent genes, yet ATF6 is not processed
in infected cells. Similarly, while Xbp-1 is activated after infection, Xbp-1 dependent transcription of EDEM does
not occur [4]. Thus, while infection activates the UPR, HCMV specifically manipulates the UPR to best benefit
virus replication.
The third arm of the UPR involves activation of the PERK. Dissociation from BiP activates PERK, which then
phosphorylates eIF2α. This results in a global reduction in translation, preventing the synthesis of new proteins
into the already overtaxed ER. In addition, eIF2α phosphorylation enhances the translation of a specific subset of
mRNAs that encode proteins involved in resolving ER stress [19]. Thus, eIF2α phosphorylation by PERK allows the
cell to both prevent further accumulation of unfolded proteins and reduce their levels within the ER. PERK levels
increase during infection and PERK expression is necessary for efficient HCMV replication. Depletion of PERK
prevents the increase in lipogenesis observed during infection and inhibits viral growth [9]. Despite increased PERK
abundance, it remains inactive until late in infection. These data again demonstrate how HCMV manipulates
complex signaling pathways to ensure successful virus replication.
Heme-regulated inhibitor kinase
In addition to activating the UPR, ER stress increases the levels of reactive oxygen species and overall levels of
oxidative stress, which activate the eIF2α kinase, heme-regulated inhibitor kinase (HRI) [20]. Oxidative stress is
observed within 30 min of HCMV infection and is critical for HCMV gene expression and virus replication [21].
Infection also stimulates NADPH oxidase, the enzyme responsible for production of superoxide [22]. However,
the effect of HCMV-induced oxidative stress on HRI expression or activity has not been examined. As HCMV
induces oxidative stress and limits eIF2α phosphorylation, it seems likely that the virus regulates HRI activation
or its ability to phosphorylate eIF2α. Perhaps, the elevated expression of antioxidants such as glutathione during
infection is sufficient to limit HRI activation. Alternatively, HCMV may express viral factors that limit HRI
activity. In transfected cells, HCMV pTRS1 limits eIF2α phosphorylation in response to arsenite [7], an HRI
agonist, suggesting that pTRS1 and pIRS1 may inhibit the activation of multiple eIF2α kinases. Further studies
are needed to understand if and how HCMV-induced stress impacts HRI signaling.
General control nonderepressible 2
High levels of translation increase the levels of deacetylated or uncharged, tRNAs in the cell. The eIF2α kinase
general control nonderepressible 2 (GCN2) is activated by binding to uncharged tRNAs [20]. Thus, as levels of
translation and uncharged tRNAs increase, so do the levels of eIF2α phosphorylation. The resulting inhibition
of translation allows the cell to restore a sufficient pool of charged tRNAs to support normal levels of protein
synthesis. GCN2 is also activated by glucose deprivation, matching the translation capacity of the cell to nutrient
availability. To date, the role of GCN2 during HCMV infection has not been examined, however it seems likely
that HCMV regulates GCN2 signaling to allow for continued viral protein expression. The high levels of viral
protein synthesis together with the ongoing synthesis of host proteins would be expected to decrease the available
pool of charged tRNAs, resulting in GCN2 activation. The metabolic demands of HCMV replication results in at
least mild nutrient deprivation, as evidenced by activation of the nutrient-sensitive kinase AMPK [23]. In addition,
the related murine cytomegalovirus caused more severe disease in mice lacking GCN2 compared with wild-type
mice [24], demonstrating an antiviral role for GCN2 in vivo. Because HCMV induces multiple stresses that could
activate GCN2 and GCN2 plays an antiviral role in murine cytomegalovirus infection, it is likely that HCMV has
mechanisms in place to limit GCN2 activation.
Future perspective
As noted above, HCMV replication induces multiple cellular stress pathways that should lead to eIF2α phospho-
rylation. Yet during early infection, no eIF2α phosphorylation occurs, due in part to HCMV proteins like pTRS1
and pIRS1 that inhibit eIF2α kinases [6,8]. It seems plausible, if not likely, that HCMV encodes additional proteins
that regulate eIF2α kinases. Future studies to identify if and how additional eIF2α kinases such as GCN2 and HRI
are regulated during infection will likely help in the identification of other viral eIF2α kinase antagonists.
HCMV also regulates eIF2α phosphorylation independent of its effect on eIF2α kinases by an unknown
mechanism. eIF2α must be dephosphorylated by protein phosphatases when cell stress is resolved in order to
resume translation and re-establish homeostasis. Previous studies show that phosphatase activity is required to
limit eIF2α phosphorylation during HCMV infection [25], suggesting that HCMV employs additional strategies
to maintain sufficient supplies of ternary complex in addition to expression of viral eIF2α kinase antagonists.
HCMV induces protein phosphatase 1 (PP1) expression [25], which could help limit eIF2α phosphorylation. Other
herpesviruses encode viral proteins that bind and recruit PP1 to phosphorylated eIF2α, such as the HSV-1 protein,
ICP 34.5 [15]. Perhaps, HCMV proteins also recruit PP1 to reverse eIF2α phosphorylation and facilitate viral
protein synthesis. In addition to regulating eIF2α phosphorylation, such viral proteins could impact other cell
signaling events as PP1 regulates multiple signaling pathways. Clearly, more work is needed to understand how
HCMV manipulates PP1 activity and target specificity and how this affects protein synthesis and cell signaling
during infection.
Interestingly, eIF2α is phosphorylated during the late stage of HCMV infection, however overall levels of
protein synthesis are not affected [4]. Further, protein synthesis becomes refractile to chemicals such as thapsigargin
that potently induce eIF2α phosphorylation late in infection [26]. The mechanism(s) by which cellular and viral
mRNAs continue to translate despite eIF2α phosphorylation is currently unknown. Perhaps, infection increases
the expression of translation factors needed for ternary complex formation. For example, infection could increase
eIF2B levels, such that low levels of eIF2α phosphorylation would not completely deplete the pool of active eIF2
complex. Alternatively, HCMV could redirect mRNAs to locations where active ternary complex accumulates or
sequestrates eIF2α kinases away from translating mRNAs, thus physically separating mRNA translation from sites
where eIF2α phosphorylation occurs. In any case, more work is needed to uncover the mechanisms that allow
HCMV mRNAs to efficiently translate in the face of eIF2α stress.
Like all viruses, HCMV infection induces a series of cell stresses that if left unchecked would inhibit viral protein
synthesis. HCMV both manipulates and mitigates cell stress responses that activate eIF2α kinases to fine-tune the
intracellular environment to support efficient virus replication. Unraveling the mechanisms HCMV uses to cope
with stressors that induce eIF2α phosphorylation that will likely provide valuable insights into both viral regulation
of cell stress and the cellular mechanisms that regulate mRNA translation.
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